InMed Pharmaceuticals Inc.: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Nov 14, 2024 and accepted by EDGAR at Nov 14, 2024, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $1.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2024-07-01 to 2024-09-30 | $771.2k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-07-01 to 2024-09-30 | $493.4k | us-gaap:GrossProfit |
| Research and development | 3 months2024-07-01 to 2024-09-30 | $771.2k | us-gaap:ResearchAndDevelopmentExpense |
| Net income | 3 months2024-07-01 to 2024-09-30 | −$1.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | −$2.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | −$2.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 620,127 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-07-01 to 2024-09-30 | −$1.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2024-09-30 | $5.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $7.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $10.5m | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $1.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $2.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-09-30 | $8.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-24-098445. Last ingested by Listed: Nov 5, 2026, 12:16 ET. Listed shows no prices and gives no investment advice.